Sequential use of thrombolytic agents for thrombosed mitral valve prosthesisduring pregnancy

Verfasser / Beitragende:
[A. H. Nassar, M. E. Abdallah, G. V. Moukarbel, I. M. Usta, W. S. Gharzuddine]
Ort, Verlag, Jahr:
2003
Enthalten in:
Journal of Perinatal Medicine, 31/3(2003-05-14), 257-260
Format:
Artikel (online)
ID: 378881019
LEADER caa a22 4500
001 378881019
003 CHVBK
005 20180305123431.0
007 cr unu---uuuuu
008 161128e20030514xx s 000 0 eng
024 7 0 |a 10.1515/JPM.2003.035  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/JPM.2003.035 
245 0 0 |a Sequential use of thrombolytic agents for thrombosed mitral valve prosthesisduring pregnancy  |h [Elektronische Daten]  |c [A. H. Nassar, M. E. Abdallah, G. V. Moukarbel, I. M. Usta, W. S. Gharzuddine] 
520 3 |a Thrombolytic therapy has gained popularity as an alternative to surgery in the treatment of prosthetic heart valve thrombosis.We report on the sequential use of streptokinase followed by recombinant tissue type plasminogen activator (rt-PA) for the treatment of a thrombosed prosthetic mitral valve in a pregnant woman at 26 weeks of gestation. Although thrombolysis was unsuccessful, the patient carried till 34 weeks of gestation and delivered by cesarean section a live newborn with an uneventful postpartum course. Based on our case and on what has been previously described in the literature, thrombolytic therapy should be considered as an option in the management of hemodynamically unstable pregnant patients with prosthetic valve thrombosis.When a single agent proves insufficient, combination therapy should be considered as it might provide hemodynamic stability and improvement in cardiac function that would allow patients at a high surgical risk to carry their pregnancy to viability. 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Human reproduction, growth & development  |2 nationallicence 
690 7 |a Gynaecology & obstetrics  |2 nationallicence 
690 7 |a Paediatric medicine  |2 nationallicence 
700 1 |a Nassar  |D A. H.  |4 aut 
700 1 |a Abdallah  |D M. E.  |4 aut 
700 1 |a Moukarbel  |D G. V.  |4 aut 
700 1 |a Usta  |D I. M.  |4 aut 
700 1 |a Gharzuddine  |D W. S.  |4 aut 
773 0 |t Journal of Perinatal Medicine  |d Walter de Gruyter  |g 31/3(2003-05-14), 257-260  |x 0300-5577  |q 31:3<257  |1 2003  |2 31  |o jpme 
856 4 0 |u https://doi.org/10.1515/JPM.2003.035  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/JPM.2003.035  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nassar  |D A. H.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Abdallah  |D M. E.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Moukarbel  |D G. V.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Usta  |D I. M.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gharzuddine  |D W. S.  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Perinatal Medicine  |d Walter de Gruyter  |g 31/3(2003-05-14), 257-260  |x 0300-5577  |q 31:3<257  |1 2003  |2 31  |o jpme 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter